THE HYPERSEROTONEMIA OF AUTISM

被引:108
|
作者
ANDERSON, GM [1 ]
HORNE, WC [1 ]
CHATTERJEE, D [1 ]
COHEN, DJ [1 ]
机构
[1] YALE UNIV, SCH MED, DEPT LAB MED, NEW HAVEN, CT 06510 USA
关键词
D O I
10.1111/j.1749-6632.1990.tb16893.x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
[No abstract available]
引用
收藏
页码:331 / 342
页数:12
相关论文
共 50 条
  • [21] Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism
    Coutinho, AM
    Oliveira, G
    Morgadinho, T
    Fesel, C
    Macedo, TR
    Bento, C
    Marques, C
    Ataíde, A
    Miguel, T
    Borges, L
    Vicente, AM
    MOLECULAR PSYCHIATRY, 2004, 9 (03) : 264 - 271
  • [22] Modeling environmental risk factors of autism in mice induces IBD-related gut microbial dysbiosis and hyperserotonemia
    Lim, Joon Seo
    Lim, Mi Young
    Choi, Yongbin
    Ko, GwangPyo
    MOLECULAR BRAIN, 2017, 10
  • [23] Hyperserotonemia in Adults with Autistic Disorder
    Dubravka Hranilovic
    Zorana Bujas-Petkovic
    Renata Vragovic
    Tomislav Vuk
    Karlo Hock
    Branimir Jernej
    Journal of Autism and Developmental Disorders, 2007, 37 : 1934 - 1940
  • [24] Modeling environmental risk factors of autism in mice induces IBD-related gut microbial dysbiosis and hyperserotonemia
    Joon Seo Lim
    Mi Young Lim
    Yongbin Choi
    GwangPyo Ko
    Molecular Brain, 10
  • [25] Hyperserotonemia in adults with autistic disorder
    Hranilovic, Dubravka
    Bujas-Petkovic, Zorana
    Vragovic, Renata
    Vuk, Tomislav
    Hock, Karlo
    Jernej, Branimir
    JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2007, 37 (10) : 1934 - 1940
  • [26] Impact of IDO activation and alterations in the kynurenine pathway on hyperserotonemia, NAD+ production, and AhR activation in autism spectrum disorder
    Launay, Jean-Marie
    Delorme, Richard
    Pagan, Cecile
    Callebert, Jacques
    Leboyer, Marion
    Vodovar, Nicolas
    TRANSLATIONAL PSYCHIATRY, 2023, 13 (01)
  • [27] Impact of IDO activation and alterations in the kynurenine pathway on hyperserotonemia, NAD+ production, and AhR activation in autism spectrum disorder
    Jean-Marie Launay
    Richard Delorme
    Cécile Pagan
    Jacques Callebert
    Marion Leboyer
    Nicolas Vodovar
    Translational Psychiatry, 13
  • [28] AN UNUSUAL NEUROLOGIC SYNDROME ASSOCIATED WITH HYPERSEROTONEMIA
    SOUTHREN, AL
    WARNER, RRP
    CHRISTOFF, NI
    WEINER, HE
    NEW ENGLAND JOURNAL OF MEDICINE, 1959, 260 (25): : 1265 - 1268
  • [29] PDE3 inhibition by cilostazol attenuated developmental hyperserotonemia induced behavioural and biochemical deficits in a rat model of autism spectrum disorder
    Luhach, Kanishk
    Singh, Bhagwat
    Aggarwal, Himanshu
    Sharma, Bhupesh
    RESEARCH IN AUTISM SPECTRUM DISORDERS, 2022, 99
  • [30] Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder
    Betancur, C
    Corbex, M
    Spielewoy, C
    Philippe, A
    Laplanche, JL
    Launay, JM
    Gillberg, C
    Mouren-Siméoni, MC
    Hamon, M
    Giros, B
    Nosten-Bertrand, M
    Leboyer, M
    MOLECULAR PSYCHIATRY, 2002, 7 (01) : 67 - 71